Immunotherapy Utilizing NK cells and ADCC Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
Ontology highlight
ABSTRACT: Immunotherapy Utilizing NK cells and ADCC Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
PROVIDER: PRJNA498086 | ENA |
REPOSITORIES: ENA
ACCESS DATA